Genetic Screening for Hemophilia: How It Works, Results and What to Expect

Genetic screening for hemophilia is a laboratory test that looks for changes in the genes linked to hemophilia A or hemophilia B. It can help confirm a diagnosis, identify carrier status, explain inheritance within a family and guide informed discussions with a hematology and genetics team.

Overview: genetic screening for hemophilia

Genetic screening for hemophilia examines DNA for changes associated with hemophilia A or hemophilia B. These inherited bleeding disorders occur when the body has too little functioning clotting factor VIII or factor IX, respectively. The test may confirm the genetic cause of an established condition, identify family members who carry a related gene change, or help clarify a suspected diagnosis.

Genetic testing is not the same as a routine blood clotting test. Factor activity tests measure how much clotting factor is present and working at the time of testing, while genetic testing looks for the underlying inherited change. Both types of information can be valuable, and a hematologist may recommend them together.

Most people who have genetic testing receive a clear result, but not every result is straightforward. A laboratory may find a known disease-causing variant, no relevant variant, or a variant of uncertain significance. Genetic counseling helps place these findings in the context of a person’s symptoms, family history and laboratory results.

What is the purpose of genetic screening for hemophilia?

The purpose of genetic screening for hemophilia is to identify a change in the F8 gene for hemophilia A or the F9 gene for hemophilia B. This can support a diagnosis, particularly when factor levels or bleeding symptoms do not provide a complete answer. It may also help distinguish inherited hemophilia from other causes of reduced clotting-factor activity.

For relatives, testing can identify whether someone carries a family-specific gene change. This may be relevant for daughters, sisters, mothers and other relatives of a person with hemophilia, although anyone can have a bleeding tendency and deserves assessment if symptoms are present. A carrier may have normal, reduced or occasionally significantly reduced factor levels, so clinical assessment remains important.

When a known familial variant is identified, the result can inform discussions about future pregnancies and testing options. The aim is to provide information and choices, not to predict every aspect of a person’s health or make decisions for them.

What is genetic screening and how does it work?

Genetic screening is the analysis of DNA to look for inherited changes associated with a health condition. For hemophilia, the laboratory usually analyzes the F8 or F9 gene. If a relative with hemophilia has already had testing and a specific variant is known, the laboratory can often perform targeted testing for that exact change in other family members.

The process generally begins with a consultation and review of personal and family bleeding history. A clinician may order clotting studies, including factor VIII or IX activity, as well as genetic testing. Before testing, genetic counseling can explain what the test can and cannot show, the possible impact on relatives and how results will be communicated.

A blood sample is most commonly collected, although some laboratories can use saliva or a cheek swab. The sample is sent to a specialized laboratory, where DNA sequencing and other methods may be used to identify small variants, larger deletions or duplications, and certain gene rearrangements. Timing for results varies according to the test and whether additional analysis is needed.

There is no recovery period after sample collection. Some people may have minor tenderness or bruising where blood was drawn. The more important follow-up step is a results appointment, where a hematologist or genetics professional explains what the result means for the individual and potentially for relatives.

How is hemophilia passed on genetically?

Hemophilia A and hemophilia B are usually inherited in an X-linked pattern. The F8 and F9 genes are located on the X chromosome. People typically assigned male at birth have one X chromosome, so a disease-causing change in their only copy of the relevant gene can lead to hemophilia.

People typically assigned female at birth have two X chromosomes. If one carries a hemophilia-related gene change, they may be described as a carrier, but this term does not fully describe bleeding risk. Some carriers have reduced factor levels and clinically important bleeding symptoms, including heavy menstrual bleeding, prolonged bleeding after dental work or excess bleeding around childbirth. Their factor levels and symptoms should be assessed individually.

An affected father passes his X chromosome to all daughters and none of his sons. A carrier mother has a chance of passing the altered X chromosome in each pregnancy; however, the exact inheritance pattern and clinical implications should be discussed with a genetics professional. In some families, hemophilia arises from a new genetic change without a known prior family history.

People with a family history may also find information on hemophilia helpful when discussing symptoms, diagnosis and long-term care with a specialist.

Who may be a candidate and what happens step by step?

A clinician may suggest genetic testing for a person diagnosed with hemophilia, someone with unexplained low factor VIII or IX levels, or an individual with a family history of the condition. It may also be considered for relatives who wish to understand carrier status before pregnancy or at another time that feels appropriate to them. Testing is voluntary, and informed consent is an important part of the process.

A typical pathway includes several steps:

• Clinical review: discussion of bleeding symptoms, prior laboratory tests, medicines and family history.
• Pre-test counseling: explanation of benefits, limitations, possible results and family considerations.
• Sample collection: usually a simple blood draw, sometimes a saliva or cheek-swab sample.
• Laboratory analysis: testing of F8, F9 or a known family-specific variant.
• Results discussion: interpretation with hematology and genetics teams, with factor testing or additional studies when needed.

Testing may not be the first step for every person with bleeding symptoms. A clinician will usually evaluate the pattern of bleeding and perform appropriate clotting tests, because disorders such as von Willebrand disease can also cause abnormal bleeding and require different assessment.

Results, benefits and limitations

A positive result means that the laboratory identified a genetic variant known to be associated with hemophilia. For someone with low factor levels and a matching clinical picture, this can confirm the inherited cause. For a relative without a diagnosis, it may indicate carrier status or an increased likelihood of passing the variant to children, depending on their chromosomes and family circumstances.

A negative result does not always rule out hemophilia or another bleeding disorder. Some variants can be difficult to detect with standard methods, and test interpretation may change as scientific knowledge develops. If bleeding symptoms or factor-test results remain concerning, the care team may recommend further testing or clinical monitoring.

A variant of uncertain significance means a DNA change was found, but current evidence does not establish whether it causes disease. This result should not be used alone to make major medical or reproductive decisions. Laboratories may reclassify variants as more evidence becomes available, and the clinical team may advise periodic review.

The benefits of testing include diagnostic clarity, more informed family discussions and the ability to tailor follow-up. Possible challenges include uncertainty, emotional stress and learning information that may be relevant to relatives. Genetic counseling before and after testing can help people prepare for these possibilities.

Safety, preparation and practical self-care

Genetic testing for hemophilia is physically low risk. For a blood draw, possible effects include brief discomfort, lightheadedness, bruising or very rarely infection at the puncture site. People with known bleeding tendencies should tell the person collecting the sample so that firm pressure can be applied afterward and any individual precautions can be followed.

Usually, no fasting or special preparation is needed unless other blood tests are planned at the same visit. Bringing available family records, previous factor-level results and information about relatives with unusual bleeding can help the clinician choose the most useful test.

While waiting for results, people with a possible bleeding disorder should follow advice from their own clinician about medicines and procedures. They should not start or stop prescribed treatment based only on a suspected genetic result. It is sensible to tell dentists, surgeons and other healthcare professionals about a known or suspected bleeding disorder before invasive procedures.

For people with confirmed hemophilia, ongoing care may include clotting-factor replacement or other treatments chosen by a specialist. The broader approach to hemophilia treatment is based on severity, bleeding pattern, factor levels and individual needs.

What are the first signs of hemophilia?

First signs of hemophilia vary with severity. In more severe cases, babies and young children may develop unusually large bruises, prolonged bleeding after blood tests or medical procedures, bleeding in the mouth after injury, or swelling and pain from bleeding into a joint or muscle. Bleeding after circumcision may also prompt assessment in some newborns.

In milder hemophilia, symptoms may not become apparent until later childhood or adulthood. A person may notice prolonged bleeding after dental work, surgery or a significant injury. Some people with mild disease have no obvious symptoms until a procedure or trauma reveals a reduced ability to clot.

Joint bleeding can cause warmth, swelling, pain, reduced movement or a tingling sensation before visible swelling develops. Repeated bleeding into the same joints can lead to joint damage over time, which is why prompt specialist assessment and a personalized treatment plan matter.

These signs can have causes other than hemophilia. Anyone with unusual, recurrent or prolonged bleeding should seek medical advice rather than self-diagnosing based on family history or online information.

When to seek medical care

Medical assessment is appropriate for unexplained frequent bruising, prolonged bleeding after cuts, dental treatment or surgery, heavy menstrual bleeding, repeated nosebleeds, or a known family history of hemophilia. A doctor can arrange appropriate clotting tests and discuss whether genetic testing is useful.

Urgent medical care is needed for a significant head injury, severe or persistent bleeding, sudden severe headache, weakness, confusion, repeated vomiting, neck pain, breathing difficulty, blood in urine or stool, or severe swelling and pain that may suggest internal bleeding. A person with diagnosed hemophilia should follow their established emergency plan and contact their treatment center promptly.

Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals can support diagnosis, genetic counseling and hemophilia care for international patients. A hematology team can help patients and families understand whether genetic testing is appropriate and how its results may guide next steps.

Frequently asked questions

Is genetic screening for hemophilia the same as a clotting-factor test?

No. Clotting-factor tests measure the activity of factor VIII or factor IX in the blood, while genetic testing looks for changes in the F8 or F9 gene. Clinicians often use both because they provide complementary information.

Can women have hemophilia?

Yes. Although hemophilia is more commonly diagnosed in people with one X chromosome, people with two X chromosomes can have low factor levels and significant bleeding symptoms. Individual factor testing and assessment by a hematologist are important.

Does a positive carrier test mean a person will have bleeding symptoms?

Not necessarily. Some carriers have normal factor levels and few symptoms, while others have reduced factor levels and clinically important bleeding. A result should be considered alongside factor activity testing and personal bleeding history.

Can hemophilia occur without a family history?

Yes. A new genetic change can occur in a person without a known family history of hemophilia. For this reason, unexplained low factor levels or characteristic bleeding symptoms may still warrant evaluation.

Is genetic testing for hemophilia safe during pregnancy?

Testing the pregnant person for a known familial variant is usually performed using a routine blood sample and is physically low risk. Testing a fetus involves different options with different benefits and risks, so this should be discussed with maternal-fetal medicine and genetic counseling specialists.

What should families do after receiving a genetic test result?

They should review the result with a hematologist or genetic counselor, who can explain what it means and whether relatives may benefit from testing. The team can also discuss factor testing, bleeding precautions and reproductive options when relevant.

References

• World Health Organization
• Centers for Disease Control and Prevention
• National Hemophilia Foundation
• World Federation of Hemophilia
• GeneReviews

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.